having sulfo-type or sialo-type mucus. Foci from normal, DC, SC, sulfo-type, or sialo-type specimens were assessed for K-ras mutation at codon 12 by nested 1 First Department of Pathology, Niigata Univerpolymerase chain reaction and restriction fragment length polymorphism. sity School of Medicine, Niigata, Japan.
RESULTS.Of the SCs, 9 were sulfo-type and 65 were sialo-type; all DC specimens 2 Department of Pathology, Tokai University were sialo-type, and all normal epithelia were sulfo-type. All foci of sulfo-type, School of Medicine, Bohseidai, Isehara, Kananonneoplastic epithelia were negative for K-ras mutation. In contrast, 124 of 313 gawa, Japan.sialo-type MCH foci (40%) had a K-ras mutation. Of 74 SCs, only 3 of 9 sulfo-type 3 Fourth Department of Internal Medicine, Tokyo tumors (33%) were positive for the mutation. Sixty of 65 sialo-type SCs (92%) had Medical College, Tokyo, Japan.a K-ras mutation, whereas 15 of 23 sialo-type DCs (65%) had a mutation. K-ras mutant carcinomas (including both SCs and DCs) were associated with K-ras mutant MCH in 109 of 198 MCHs (55%), whereas carcinomas without a K-ras mutation had mutations in 6 of 68 MCHs (9%). MCH in normal pancreata revealed K-ras mutations in 9 of 51 foci (18%). In addition, in K-ras mutant carcinomas, frequency of K-ras mutation in MCH increased from 27% (11 of 41 foci) of nonpapillary MCHs to 62% (98 of 157 foci) of papillary MCHs; but in K-ras wild-type carcinoma, the mutation rate in MCH was unchanged from 12% (3 of 26 foci) to 7% (3 of 42 foci) in nonpapillary and papillary foci, respectively. the former, whereas sialomucin is secreted by the latter. In addi-
CONCLUSIONS.